Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedA new label No longer looking for participants was added to the study page, indicating that recruitment for this trial has ended. Additionally, several navigation and help sections were added or removed to update the page structure.SummaryDifference0.4%

- Check12 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a back-end or front-end update. The change reflects an update to the page's underlying versioning rather than content changes to the study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new page revision label Revision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This indicates the page has been updated to a newer version.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page footer’s revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.